FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...
Vous n'êtes pas connecté
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety levels two to four hours after ingestion, according to a study published online Dec. 16 in JAMA Network...
FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...
Cannabidiol (CBD) had no effect on scan-related anxiety (scanxiety), but it significantly eased overall anxiety in women with advanced breast...
The findings showed that CBD did not significantly change scan-related anxiety when compared to a placebo, but researchers did find that CBD was safe...
Scan-related anxiety, often referred to as 'scanxiety,' is particularly common among cancer patients due to the stress and uncertainty surrounding...
FRIDAY, Dec. 13, 2024 -- The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or...
A recent study has revealed a significant gap between guidelines and clinical practice in the treatment of metastatic prostate cancer. A survey of...
FRIDAY, Dec. 13, 2024 -- Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically...
TUESDAY, Dec. 10, 2024 -- Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for breast, cervical,...
TUESDAY, Dec. 10, 2024 -- Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for breast, cervical,...
Daily walking could help reduce the risks of clinical depression, according to a study published Monday in JAMA Network Open.